Infinity Pharmaceuticals Inc
OTC:INFIQ

Watchlist Manager
Infinity Pharmaceuticals Inc Logo
Infinity Pharmaceuticals Inc
OTC:INFIQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 91 USD
Have any thoughts about
Infinity Pharmaceuticals Inc?
Write Note

Gross Margin
Infinity Pharmaceuticals Inc

40%
Current
40%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
40%
=
Gross Profit
1m
/
Revenue
2.5m

Gross Margin Across Competitors

Country US
Market Cap 91 USD
Gross Margin
40%
Country US
Market Cap 360B USD
Gross Margin
67%
Country US
Market Cap 172B USD
Gross Margin
63%
Country US
Market Cap 122.8B USD
Gross Margin
86%
Country US
Market Cap 110.7B USD
Gross Margin
77%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country US
Market Cap 93.1B USD
Gross Margin
87%
Country AU
Market Cap 138.7B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 34.1B USD
Gross Margin
87%
Country NL
Market Cap 32.4B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Infinity Pharmaceuticals Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
40%
=
Gross Profit
1m
/
Revenue
2.5m
What is the Gross Margin of Infinity Pharmaceuticals Inc?

Based on Infinity Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 40%.